Who
Christopher Thomas Giordano
CEO
Company insider
Files Form 4 as: CEO, Tenax Therapeutics.
In numbers
- Trades disclosed
- 21
- Buys
- 5
- Sells
- 0
- Bought
- $60K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 9 Jun 2022
- Last trade
- 15 Sep 2026
- Last filed
- 15 Sep 2026
Companies traded
Activity over time
1 Nov 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Sep 2026filed 15 Sep 2026 | TENX Tenax TherapeuticsBiotechnology | SEC FORM 4 Bought | $8,8374,850 at $1.82 | filing |
| 15 Sep 2026filed 15 Sep 2026 | TENX Tenax TherapeuticsBiotechnology | SEC FORM 4 Bought | $8,8274,850 at $1.82 | filing |
| 11 Sep 2026filed 15 Sep 2026 | TENX Tenax TherapeuticsBiotechnology | SEC FORM 4 Bought | $11K6,000 at $1.88 | filing |
| 11 Sep 2026filed 15 Sep 2026 | TENX Tenax TherapeuticsBiotechnology | SEC FORM 4 Bought | $11K6,000 at $1.88 | filing |
| 13 Jul 2026filed 14 Jul 2026 | TENX Tenax TherapeuticsBiotechnology | SEC FORM 4 Code M | $777219 at $3.55 | filing |
| 13 Jul 2026filed 14 Jul 2026 | TENX Tenax TherapeuticsBiotechnology | SEC FORM 4 Code M | $50K8,500 at $5.94 | filing |
| 13 Jul 2026filed 14 Jul 2026 | TENX Tenax Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —219 at $0.00 | filing |
| 13 Jul 2026filed 14 Jul 2026 | TENX Tenax Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —219 at $0.00 | filing |
| 13 Jul 2026filed 14 Jul 2026 | TENX Tenax Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —8,500 at $0.00 | filing |
| 13 Jul 2026filed 14 Jul 2026 | TENX Tenax Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —8,500 at $0.00 | filing |
| 13 Jul 2026filed 14 Jul 2026 | TENX Tenax TherapeuticsBiotechnology | SEC FORM 4 Code M | $777219 at $3.55 | filing |
| 13 Jul 2026filed 14 Jul 2026 | TENX Tenax TherapeuticsBiotechnology | SEC FORM 4 Code M | $50K8,500 at $5.94 | filing |
| 9 Jan 2026filed 13 Jan 2026 | TENX Tenax Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —450,000 at $0.00 | filing |
| 9 Jan 2026filed 13 Jan 2026 | TENX Tenax Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —450,000 at $0.00 | filing |
| 20 Nov 2025filed 20 Nov 2025 | TENX Tenax TherapeuticsBiotechnology | SEC FORM 4 Bought | $4,083538 at $7.59 | filing |
| 19 Nov 2025filed 20 Nov 2025 | TENX Tenax TherapeuticsBiotechnology | SEC FORM 4 Bought | $3,417455 at $7.51 | filing |
| 18 Nov 2025filed 20 Nov 2025 | TENX Tenax TherapeuticsBiotechnology | SEC FORM 4 Bought | $12K1,612 at $7.75 | filing |
| 16 May 2025filed 20 May 2025 | TENX Tenax Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,400,000 at $0.00 | filing |
| 10 Dec 2024filed 12 Dec 2024 | TENX Tenax Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,250,000 at $0.00 | filing |
| 17 May 2024filed 21 May 2024 | TENX Tenax Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —437 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.